2-(Difluoromethyl)-1,4-difluorobenzene, 98%, 250mg

7-oxo-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid, 95.0%, 1g

N,N,N',N'-Tetramethylfluoroformamidinium hexafluorophosphate, 98.0%, 1g

4-Bromo-2-chloro-5-(trifluoromethyl)benzaldehyde, 97%, 1g

Developing chambers for TLC, Suitable for, up to 5 plates up to 20 x 20 cm plate size, 1 Piece(s)

3-Chloro-2,4-dimethylphenol, 95%, 1g

Aprocitentan, 5mg

3-Formyl-4-hydroxybenzoic acid, 95.0%, 100g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-cyclohexyl-L-alanine>98.0%(HPLC)(T)5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid, 98%, 1g

8-Methoxyquinazolin-4-ol, 95.0%, 1g

5-Hydroxy-1H-imidazole-4-carboxamide, 95.0%, 25g

2-cyano-4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g